MedPath

CREON MINIMICROSPHERES 35

CREON MINIMICROSPHERES 35

Approved
DIN Number

02494639

Drug Class

Human

Market Date

Jan 26, 2021

Company
HC

BGP Pharma ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02494639
AIG Number0302964045
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Product Specifications
Dosage FormCapsule (Delayed Release)
Route of AdministrationOral
AHFS Classification56:16.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

AMYLASEActive
Strength: 35700 UNIT
Monograph: AMYLASE
LIPASEActive
Strength: 35000 UNIT
Monograph: LIPASE
PROTEASEActive
Strength: 2240 UNIT
Monograph: PROTEASE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.